Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The purpose of ZA-301 is to determine the effects of Androxal on morning testosterone and reproductive status in younger overweight men with acquired hypogonadotropic hypogonadism (confirmed morning T\<300 ng/dL) and normal sperm concentration, compared to changes with placebo. Subjects must not have previously been treated with testosterone products within the last 6 months.
Epistemonikos ID: 8edbf050b114ac734533af02f947fb5081782e1d
First added on: May 10, 2024